CVT 510,
CVT-510,
N-(3-tetrahydrofuranyl)-6-aminopurine riboside,
tecadenoson,
Tecadenoson,
CVT-510,
UNII-GZ1X96601Z,
CHEMBL392149,
GZ1X96601Z,
204512-90-3,
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-oxolan-3-yl]amino]purin-9-yl]oxolane-3,4-diol,
BDBM50224766,
Tecadenoson (USAN/INN),
Tecadenoson [USAN:INN],
AC1L4KMO,
SCHEMBL246787,
CHEMBL356254,
GTPL5592,
DTXSID80174415,
BDBM50138530,
DB04954,
N6-[3-(R)-tetrahydrofuranyl]adenosine,
HY-19661,
Adenosine, N-(3R)-tetrahydro-3-furanyl-,
Adenosine, N-(3R)-tetrahydro-3-furanyl)-,
LS-190860,
CS-0016174,
D06019,
(2R,3R,4S,5R)-2-Hydroxymethyl)-5-(6-((3R)-(tetrahydrofuran-3-ylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol,
(2R,3R,5R)-2-Hydroxymethyl-5-{6-[(R)-(tetrahydro-furan-3-yl)amino]-purin-9-yl}-tetrahydro-furan-3,4-diol,
(2R,3S,4R)-2-Hydroxymethyl-5-{6-[(R)-(tetrahydro-furan-3-yl)amino]-purin-9-yl}-tetrahydro-furan-3,4-diol,
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((R)-tetrahydrofuran-3-ylamino)-9H-purin-9-yl)-tetrahydrofuran-3,4-diol,
2-(6-(((3R)Oxolan-3-yl)amino)purin-9-yl)(2R,4S,3R,5R)-5-(hydroxymethyl)oxolane-3,4-diol,
Selenocompounds,
Tecadenoson[USAN],
Tecadenoson [USAN],
D00YSJ,
D0J5LJ,
CID158795,
C14-H19-N5-O5,
N-[(3R)-Tetrahydro-3-furanyl]adenosine,
N-(3-Tetrahydrofuranyl)-6-aminopurine riboside,
204512-89-0,